Journal article
Medical and social scientists as strategic advisors: the case of GloPID-R in 2021
- Abstract:
- Many tech firms and government departments have senior executives whose day job is science. How they can also work as strategists has received little attention. We relate how leading scientists set mid-term research funding priorities worth billions of dollars while addressing the COVID-19 pandemic. Using scenario planning, they utilized a phenomenological epistemology better suited to strategy in turbulent conditions (such as the pandemic) instead of the dominant positivism in their scientific work. This article provides insights for scientists interested in strategy and those seeking to reframe an urgent situation with the help of a useful longer-term perspective.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
- Publisher:
- SAGE Publications
- Journal:
- California Management Review More from this journal
- Volume:
- 65
- Issue:
- 3
- Publication date:
- 2023-05-01
- Acceptance date:
- 2023-03-21
- EISSN:
-
2162-8564
- ISSN:
-
0008-1256
- Language:
-
English
- Keywords:
- Pubs id:
-
1333995
- Local pid:
-
pubs:1333995
- Deposit date:
-
2023-03-23
Terms of use
- Copyright holder:
- Paparella et al.
- Copyright date:
- 2023
- Rights statement:
- ©2023 The Authors. Reuse is restricted to non-commercial and no derivative uses.
- Notes:
- This is the accepted manuscript version of the article. The final version is available from SAGE Publications at: https://cmr.berkeley.edu/2023/05/medical-and-social-scientists-as-strategic-advisors-the-case-of-glopid-r-in-2021/.
If you are the owner of this record, you can report an update to it here: Report update to this record